Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Multiple Dose Combinations of SION-451 and Complementary Modulators SION-2222 and SION-109 in Healthy Participants. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating safety, tolerability, and pharmacokinetics of multiple-dose combinations of SION-451 with SION-2222 and SION-109 in hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• SION-109
• SION-2222
• SION-451

Snippet

Sponsor: Sionna Therapeutics Inc. | Conditions: Cystic Fibrosis (CF) | Phase 1 | Status: RECRUITING